JD-5037 Inhibitor

Name: JD-5037 Inhibitor; MyBioSource
Brand: MyBioSource
SKU: MBS5750565
Availability: InStock
Rating: 5 (10 reviews)

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5750565

JD-5037 is a novel, peripherally restricted CB1R antagonist with an IC50 of 1.5 nM. More details

Please Inquire

Product Documentation

Sample Manual Insert View PDF

Testing Data View PDF

Certificate of Analysis (COA) View PDF

QC Report View PDF

Material Safety Data Sheet View PDF

Technical Datasheet View PDF

Protocol View PDF

Product Overview

Online Datasheet in PDF

Product Name

JD-5037, Inhibitor

Full Product Name

JD-5037

Product Gene Name

JD-5037, inhibitor

Product Synonym Names

Cannabinoid Receptor

Form/Format

POWDER

Purity/Purification

98.00%

Preparation and Storage

Powder: 3 years -20 degree C
In Solvent: 2 years -80 degree C

Molecular Weight

572.51

CAS Number

1392116-14-1

Formula

C27H27Cl2N5O3S

Smiles

CC(C)[C@H](\N=C(\NS(=O)(=O)c1ccc(Cl)cc1)N1C[C@@H](C(=N1)c1ccc(Cl)cc1)c1ccccc1)C(N)=O

Solubility

DMSO: 10 mM

Pathways

GPCR; G Protein

Receptor

CB1R

Product Remark

For obtaining a higher solubility, please warm the tube at 37 degree C and shake it in the ultrasonic bath for a while. Stock solution can be stored below -20 degree C for several month.

Product Categories/Family for JD-5037, inhibitor

Endocrine Metabolic Disease; Diabetes Mellitus; Hyperlipidaemia

Product References and Citations for JD-5037, inhibitor

1. Knani I,etal.Targeting the endocannabinoid/CB1 receptor system for treating obesity in Prader-Willi syndrome.Mol Metab. 2016 Oct 22; 5(12):1187-1199.

Other Notes

Small volumes of JD-5037, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for JD-5037 purchase

MBS5750565 is an inhibitor targeting JD-5037.